1 / 7

Terbium-161 Without Delays How Our Centre Ensures a Reliable Supply for Timely Cancer Treatment

Terbium-161 is a next-generation radionuclide offering promising outcomes in targeted cancer therapy. Timely access to this therapy is critical for patient success, and our centre has established a robust supply chain to prevent treatment delays. Through global partnerships, real-time inventory management, and expert logistics, we ensure uninterrupted availability of Tb-161u2014allowing patients to receive personalized and effective cancer care without compromise.<br>More information available at nuclearmedicinetherapy.in

Nuclearmedicinetherapy
Download Presentation

Terbium-161 Without Delays How Our Centre Ensures a Reliable Supply for Timely Cancer Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nuclear Medicine Centre FMRi Gurugram INDIA Dr. Ishita B Sen How Our Centre Ensures a Reliable Supply for Timely Cancer Treatment www.nuclearmedicinetherapy.in

  2. Introductionto Terbium-161 (Tb-161) • Tb-161 is an advanced radionuclide used in precision cancer therapy • Offers dual radiation (β- and Auger electrons) for higher tumor-killing efficiency • Considered the next-gen alternative to Lutetium-177 • More Info: https://nuclearmedicinetherapy.in/post/terbium-161-without-delays-how-our-centre-ensures-a-reliable-supply-for-timely-cancer-treatment

  3. Importance of Timely Access • Cancer patients require uninterrupted treatment cycles • Delays in radionuclide availability can affect therapeutic outcomes • Reliability in supply ensures continuity and better prognosis

  4. Our Centre’s Supply Strategy • Strategic partnerships with global isotope suppliers • In-house logistics and coordination team for handling short half-life isotopes • Real-time inventory monitoring and pre-scheduling of doses

  5. Benefits to Patients • On-time treatment planning and execution • Reduced risk of therapy interruption • Increased confidence in treatment outcomes • Enhanced patient satisfaction and trust

  6. Our Commitment to Excellence • State-of-the-art nuclear medicine infrastructure • Experienced team in radiopharmaceutical handling • Constant research and process improvements to support patient care

  7. For more information talk to Dr. Ishita B Sen today. dr.ishitasen@nuclearmedicinetherapy.in +91 8700 668 431 www.nuclearmedicinetherapy.in

More Related